The use of reference pricing by health insurers and employee health benefit plans stands high on the policy and regulatory agenda because it is gaining popularity, particularly now that federal ...
Reference pricing — or capping payment for a specific healthcare service — offers only modest potential savings for health plans and purchasers looking to contain costs, according to an analysis ...
Reference-based pricing entered the conversation a few years ago as a solution and response to unsustainable healthcare price increases, and the model is still gaining traction among self-funded ...
Insurers and employers take note: A new study has found that reference pricing is associated with “significant” changes in drug selection and spending for patients covered by employer-based insurance.
(Reuters Health) - When employers and insurers use reference pricing for diagnostic tests, the average price paid for those tests dips by almost a third, according to a new U.S. study. Under reference ...
Reference pricing has been touted as a way to create provider competition in healthcare, but a recent Federal Trade Commission article argued this isn't the case. Reference pricing is a relatively new ...
A reference pricing initiative was linked to more prescription fills of lowest-priced drugs and a decreased average price per prescription, but higher rates of copayments by patients, a new study ...
Reference-based pricing combined with employer education and an online shopping tool significantly improved members' utilization of lab services at or below the reference price The study group ...
The Trump administration has proposed using international pricing of drugs to establish ceilings on what Medicare will pay for therapies administered by physicians in their offices or in hospital ...
Reference pricing leverages a shopping model with an allowance component to give employees an incentive for comparing providers for particular procedures by shifting any costs above a target price to ...
Forbes contributors publish independent expert analyses and insights. Wayne Winegarden covers the economic impacts of regulatory policies All of this innovation does not come cheap. Developing one new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results